Skip to main content
Sonnet BioTherapeutics Holdings, Inc. (SONN)
NASDAQ: SONN · Real-Time Price · USD
1.560
-0.030 (-1.89%)
Dec 20, 2024, 4:00 PM EST - Market closed

SONN Revenue

In the fiscal year ending September 30, 2024, Sonnet BioTherapeutics Holdings had annual revenue of $18.63K, down -87.40%.

Revenue (ttm)
$18.63K
Revenue Growth
-87.40%
P/S Ratio
54.88
Revenue / Employee
$1,552
Employees
12
Market Cap
4.69M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Sep 30, 202418.63K-129.18K-87.40%
Sep 30, 2023147.81K-202.14K-57.76%
Sep 30, 2022349.94K-133.68K-27.64%
Sep 30, 2021483.63K--
Sep 30, 2020---
Sep 30, 2019 Pro Pro Pro
Sep 30, 2018 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Healthcare Triangle 16.57M
Biomerica 5.51M
Sintx Technologies 3.25M
Predictive Oncology 1.48M
FOXO Technologies 1.34M
Revenue Rankings

SONN News

More News